Related Experiment Video
Updated: May 19, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Inclusion of the risk score in decision making of valvular heart disease
Ricardo Casalino1, Max Grinberg
1Instituto do Coração, São Paulo, SP, - Brasil. ricardocasalino@cardiol.br
Insights
Clinical data and risk scores aid decisions for valvular heart disease patients. However, current risk scores like EuroSCORE, STS, and Ambler lack validation in our specific population for predicting mortality.
Area of Science:
- Cardiology
- Medical Statistics
Background:
- Valvular heart disease management relies on clinical data and survival interpretations.
- Decision-making for interventions requires understanding patient quality of life and prognosis.
- Interdisciplinary expertise is crucial for optimizing outcomes in valvular heart disease treatment.
Purpose of the Study:
- To evaluate the utility of risk scores in predicting postoperative mortality for valvular heart disease patients.
- To assess the applicability of existing risk stratification tools in a specific patient population.
Main Methods:
- Utilized clinical facts and numerical data for quality of life and survival analysis.
- Examined the role of validated risk scores incorporating multiple markers.
- Assessed the predictive accuracy of established tools such as EuroSCORE, STS score, and Ambler Score.
Main Results:
- Risk scores offer quantitative accuracy to clinical assessments, aiding in objective patient evaluation.
- Existing risk stratification tools provide valuable data for predicting postoperative mortality.
- None of the commonly used risk scores (EuroSCORE, STS, Ambler) have been validated within the study's population.
Conclusions:
- Risk scores are valuable, user-friendly tools for assessing patient risk in valvular heart disease.
- The lack of local validation for existing risk scores highlights a gap in current clinical practice.
- Further research is needed to validate or develop appropriate risk stratification tools for this population.
Abstract:
Clinical facts and numerical data support interpretations of quality of life and survival in patients with valvular heart disease. Such data are useful in decision making regarding the interruption of natural history and replacement by a hemodynamic post-correction history. Interdisciplinary competence and expertise are required to maximize the necessary and possible results. However, the ideal of recommendations to achieve the highest degree of therapeutic satisfaction by patients with valvular heart disease is influenced by a set of variables, related in part to the specifications of the patient, and part to the limitations of methods. The rationale of the risk score validated for multiple markers is the addition of quantitative accuracy to the clinical assessment based on the heterogeneity of individual experience and intuition. In this context, the use of risk scores to predict postoperative mortality are useful tools, easy to apply and that gives us objective data on the patient's situation. None of the available tools (EuroSCORE, STS score and Ambler Score) used in healthcare has been validated has in our population.
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Mitral Stenosis IV: Nursing Management
Rheumatic Heart Disease III: Medical Management
